MétaCan
Menu
Back to cohort
Record W3211242169 · doi:10.1007/s00415-021-10881-3

The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience

2021· article· en· W3211242169 on OpenAlexafffund
Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, Jeremy Chataway, Nancy D. Chiaravalloti, Gary Cutter, Ulrik Dalgas, John DeLuca, Rachel Farrell, Peter Feys, Massimo Filippi, Jennifer Freeman, Matilde Inglese, Cecilia Meza, Rob Motl, Maria A. Rocca, Brian M. Sandroff, Amber Salter

Bibliographic record

VenueJournal of Neurology · 2021
Typearticle
Languageen
FieldMedicine
TopicMultiple Sclerosis Research Studies
Canadian institutionsHealth Sciences CentreUniversity of TorontoSunnybrook Health Science Centre
FundersSanofi GenzymeHorizon 2020 Framework ProgrammeFondazione Italiana di Ricerca per la Sclerosi Laterale AmiotroficaMedDay PharmaceuticalsMinistero della SaluteNational Institutes of HealthRosetrees TrustUniversity College LondonNational Heart, Lung, and Blood InstituteMultiple Sclerosis SocietyMultiple Sclerosis Society of CanadaBioDelivery Sciences InternationalSanofiGW PharmaceuticalsTG TherapeuticsMultiple Sclerosis Scientific Research FoundationEli Lilly and CompanyUniversity of AlabamaFondation pour l'Aide à la Recherche sur la Sclérose en PlaquesNational Institute for Health and Care ResearchCSL BehringBristol-Myers SquibbCelgeneFondazione Italiana Sclerosi MultiplaAveXisPfizerBiogenAlexion PharmaceuticalsMedical Research CouncilTeva Pharmaceutical IndustriesEuropean Genomic Institute for DiabetesHorizon PharmaceuticalsGenentechNational Multiple Sclerosis Society
KeywordsPandemicRehabilitationPsychological interventionMedicineRandomized controlled trialIntervention (counseling)OptimismNeurologyCoronavirus disease 2019 (COVID-19)Physical therapyPsychologyDiseasePsychiatryInfectious disease (medical specialty)

Abstract

fetched live from OpenAlex

Pandemic restrictions have led to changes in therapy plans and disrupted rehabilitation services for people with multiple sclerosis. CogEx is an international, multicentre MS dual-intervention (cognitive rehabilitation, aerobic exercise) randomized, controlled rehabilitation trial confined to people with progressive disease. The primary outcome is cognition (processing speed).There are 11 treatment sites in six countries with participants required to make 27 site visits over 12 weeks. Collectively, the large, in-person demands of the trial, and the varying international policies for the containment of COVID-19, might disproportionately impact the administration of CogEx. During the first lockdown, all centres closed on average for 82.9 (SD = 24.3) days. One site was required to lockdown on two further occasions. One site remained closed for 16 months. Ten staff (19.2%) were required to quarantine and eight staff (15.4%) tested positive for COVID. 10 of 264 (3.8%) participants acquired COVID-19. All survived. The mean duration of enrollment delay has been [236.7 (SD = 214.5) days]. Restarting participants whose interventions were interrupted by the pandemic meant recalculating the intervention prescriptions for these individuals. While the impact of the pandemic on CogEx has been considerable, all study sites are again open. Participants and staff have shown considerable flexibility and resilience in keeping a complex, international endeavour running. The future in general remains uncertain in the midst of a pandemic, but there is cautious optimism the study will be completed with sufficient sample size to robustly evaluate our hypothesis and provide meaningful results to the MS community on the impact of these interventions on people with progressive MS.Trial registration: The trial was registered on September 20th 2018 at www.clinicaltrials.gov having identifier NCT03679468. Registration was performed before recruitment was initiated.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.063
metaresearch head score (Gemma)0.041
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.063
Threshold uncertainty score0.333

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0630.041
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0040.003
Scholarly communication0.0060.004
Open science0.0010.006
Research integrity0.0020.004
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.125
GPT teacher head0.473
Teacher spread0.348 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueJournal of NeurologySame topicMultiple Sclerosis Research StudiesFrench-language works237,207